Alberts, DS and Liu, PY and Hannigan, EV and O'Toole, R. and Williams, SD and Young, J. and Franklin, D. and Clarke-Pearson, VK and Malvyia, B. and DuBeshter, W. and others

Proc Am Soc Clin Oncol

Phase III study of intraperitoneal (IP) cisplatin (CDDP)/intravenous (IV) cyclophosphamide (CPA) VS IV CDDP/IV CPA in patients (PTS) with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG intergroup study (INT 0051)

1995

Validated

()